🔗 Share this article

A shadow market for unapproved weight-loss medications is being driven by TikTok fitness influencers and vendors on communication apps, based on new investigations.

Investigational Drug Gaining Traction Via Social Media

The experimental drug, which is still in clinical trials, is being advertised by social media influencers for its supposed fat-burning effects. Viewers are urged to contact these accounts privately for supplier links, while also receiving promotional offers.

Thriving Trade on Social Networks

Additionally, a robust trade exists on messaging services, where communities with thousands of participants share comparison images, injection guides and assertions of next-day UK delivery. Vendors promote the drug there before redirecting customers to other platforms for transactions.

Learning About Retatrutide

This medication is an experimental injectable created by American pharmaceutical company Eli Lilly. The treatment targets three intestinal hormones – GLP-1, GIP and glucagon. Preliminary studies indicate it could help patients reduce up to 25% of their body weight. Nicknamed the “triple G”, the substance is being hailed online as the next Ozempic.

Healthcare Professionals Voice Concerns

Nevertheless, physicians and chemists have warned that the distribution of what remains an unapproved drug in the UK is a cause for concern and could lead to individuals administering substances of unknown origin.

Several professionals said the popularity for retatrutide could be linked to the increasing price of approved slimming treatments such as Mounjaro.

Regulatory Status and Implementation

Selling the unapproved drug on social media or Telegram is illegal in the United Kingdom, as it is an unapproved medication that must not be promoted or distributed for personal consumption under the Human Medicines Regulations 2012.

Some influencers attempt to sidestep the rules by calling to the drug as a “research chemical” or describing it as “not for human consumption”. The substance is not a restricted drug, but advertising and distribution can still breach pharmaceutical, advertising, and consumer regulations, risking fines, prosecution or prison.

Service Response and Content Removal

According to TikTok, the platform has taken down problematic material and banned associated keywords and search suggestions. The organization stated it was committed to maintaining the platform safe and allocating resources in strengthening compliance measures.

Online Trading Operations

Research also discovered groups with up to 9,000 participants marketing the experimental drug using the platform's integrated discovery tool, which functions like a online catalog. Typing “retatrutide” instantly displays channels with numerous of members, populated with images of slimming results, glowing testimonials and detailed guides for preparing or administering at home.

Within minutes of joining one community, a seller shared WhatsApp details, where the majority of transactions take place. The seller sent an guidebook and promised delivery within two days. When asked whether the substance was authentic, one seller responded: “You can’t be sure.” Another provided a image of a supposed laboratory certificate. None asked about weight, health issues or previous experience.

Product Details and Costs

Within these communities, posts display black plastic parcels with postal service stickers, claiming to contain new batches. One message read: “It took eight of us to load them this morning.”

Customers can choose between powder vials, mixed at residence with purified liquid, or ready-to-use pens usually priced at £160 for 20mg. When asked how much time a injector should be used, sellers give contradictory answers ranging from a several days to “depends on your body”.

Platform Oversight and Safety Measures

A representative for Telegram stated it actively moderated dangerous material on its service including material that promoted the “misuse of controlled medications”. The company noted that it removed “millions of pieces of harmful content each day”.

Healthcare Professional Warnings

“People are administering substances they can’t verify. Even if the science behind this drug is valid, these online versions may not include what they claim,” said a pharmacy expert, the director of pharmacy at Chemist4U.

A medical professional of an online medical service linked the surge in demand to recent cost increases for authorized weight-loss drugs such as Mounjaro. “With prices rising, patients are turning to social media. But counterfeit injections are highly risky. You can’t be certain what’s inside or whether the environment they were made in was sterile,” she explained.

Her staff has previously seen patients harmed by personal administration from unconfirmed suppliers. “We recognize the disappointment, but buying from messaging apps or communication platforms is gambling with your health,” said the doctor. “These materials could be contaminated or improperly measured.”

Producer Position

A representative from the pharmaceutical company stated the substance was in phase 3 clinical trials and had not been reviewed or approved by any government authority anywhere in the world. “Consequently at this time no one can sell [it] for personal consumption,” they explained, adding that any item “misleadingly claiming itself as a company experimental substance not yet authorized … may expose users to potentially significant medical dangers”.